Olabisi Tajudeen Obafemi

Dr. Olabisi Tajudeen Obafemi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
OOOlabisi Tajudeen Obafemi
Olabisi Tajudeen Obafemi
AAA.C. Akinmoladun
A.C. Akinmoladun
MOM.T. Olaleye
M.T. Olaleye
SAStephen O. Agboade
Stephen O. Agboade
AOAmos A. Onasanya
Amos A. Onasanya
Synsepalum dulcificum is a plant indigenous to West Africa. The fruit is used to modify taste of foods to sweetness. This study aims to investigate the antidiabetic potentials of both methanolic and flavonoid-rich leaf extracts of S. dulcificum (MSD and FSD respectively) in type 2 diabetic Wistar albino rats. Sixty three rats were randomly distributed into nine groups of seven animals each with group 1 serving as the normal control. Groups 2 to 7 were given 10% fructose in their drinking water for 14 days, after which 40 mg/kg of streptozotocin was administered. Group 2 animals served as the diabetic control, while groups 3, 4, 5, 6 and 7 were treated with 30 mg/kg MSD, 60 mg/kg MSD, 30 mg/kg FSD, 60 mg/kg FSD and 5 mg/kg glibenclamide respectively. Groups 8 and 9, contained healthy animals, and were treated with only 60 MSD, and 60 mg/kg FSD respectively. Biochemical parameters such as liver and kidney function tests, lipid profile, as well as lipid peroxidation and antioxidant enzymes were assessed in addition to histopathology. It was observed that daily oral administration of MSD and FSD for 21 days significantly (p < 0.05) improved the observed pathological changes as a result of type 2 diabetes. It could be deduced from results obtained in this study that methanolic and flavonoid-rich leaf extracts of S.dulcificum have antidiabetic potential in type 2 diabetic rats.

31 December 2024 in Heliyon
Verified
Journal Article
Open access
OOOlabisi Tajudeen Obafemi
Olabisi Tajudeen Obafemi
AAAdemola Olabode Ayeleso
Ademola Olabode Ayeleso
OAOlusola Bolaji Adewale
Olusola Bolaji Adewale
JUJeremiah Unuofin
Jeremiah Unuofin
BEBidemi Emmanuel Ekundayo
Bidemi Emmanuel Ekundayo
SLSogolo Lucky Lebelo
Sogolo Lucky Lebelo
Animal models have become veritable tools in gaining insight into the pathogenesis and progression of several human diseases. These models could range in complexity from Caenorhabditis elegans to non-human primates. With the aid of these animal models, a lot of new knowledge has been gained about several diseases which otherwise would not have been possible. Most times, the utilization of these animal models is predicated on the level of homology they share with humans, which suggests that outcomes of studies using them could be extrapolated to humans. However, this has not always been the case. Drosophila melanogaster is becoming increasingly relevant as preferred model for understanding the biochemical basis of several human diseases. Apart from its relatively short lifespan, high fecundity and ease of rearing, the simplicity of its genome and lower redundancy of its genes when compared with vertebrate models, as well as availability of genetic tool kit for easy manipulation of its genome, have all contributed to its emergence as a valid animal model of human diseases. This review aimed at highlighting the contributions of selected animal models in biomedical research with a focus on the relevance of Drosophila melanogaster in understanding the biochemical basis of some diseases that have continued to plague mankind.

12 May 2021 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
OOOlabisi Tajudeen Obafemi
Olabisi Tajudeen Obafemi
OOOlutumise V. Owolabi
Olutumise V. Owolabi
BOBenjamin O. Omiyale
Benjamin O. Omiyale
BABlessing A. Afolabi
Blessing A. Afolabi
OOOluwafemi A. Ojo
Oluwafemi A. Ojo
DRDamilare Rotimi
Damilare Rotimi

11 November 2022 in Pharmacological Research - Modern Chinese Medicine
Verified
Journal Article
Open access
BEBidemi Emmanuel Ekundayo
Bidemi Emmanuel Ekundayo
OOOlabisi Tajudeen Obafemi
Olabisi Tajudeen Obafemi
BABlessing Ariyo Afolabi
Blessing Ariyo Afolabi
OAOlusola Bolaji Adewale
Olusola Bolaji Adewale
AOAmos Onasanya
Amos Onasanya
IAIsaac Adekola Adu
Isaac Adekola Adu


1 January 2021 in Toxicology Reports
Verified
Journal Article
Open access
OOOlabisi Tajudeen Obafemi
Olabisi Tajudeen Obafemi
KJKikelomo F. Jaiyesimi
Kikelomo F. Jaiyesimi
AOAdenike A. Olomola
Adenike A. Olomola
OOOluwaseun R. Olasehinde
Oluwaseun R. Olasehinde
OOOyindamola A. Olaoye
Oyindamola A. Olaoye
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
• Metformin, gallic acid and a combination of both improved glucose metabolism and antioxidant status in diabetic rats. • Metformin, gallic acid and a combination of both lowered levels of IL-6 and TNF-α in liver and pancreas of diabetic rats. • Metformin, gallic acid and a combination of both decreased the expression of ATF4 in liver and pancreas of diabetic rats. • Metformin/GA combination appeared more effective than metformin only and gallic acid only.